Acute Lymphoblastic Leukaemia
Acute Lymphoblastic Leukaemia (ALL) is a fast-growing cancer of the blood and bone marrow that primarily affects white blood cells known as lymphoblasts. Unlike chronic leukaemia, which progresses slowly, ALL develops suddenly and aggressively, requiring urgent diagnosis and treatment.
ALL is the most common cancer in children, but it also affects adults, especially those over 65. In South Africa, where access to haematology services may vary between rural and urban settings, early detection remains critical to saving lives.
What Happens in ALL?
In ALL, the bone marrow produces abnormal lymphocytes in large quantities. These immature cells crowd out healthy cells, leading to a shortage of red cells, platelets, and normal white cells. The result is a combination of anaemia, bleeding problems, and infections.
Fast Facts:
- Most common childhood cancer
- Also affects adults, with more severe outcomes
- Treatable, and often curable with early intervention
- Requires intensive chemotherapy and sometimes stem cell transplant
Globally, ALL has high survival rates in children (80–90%) with proper treatment. In South Africa, public healthcare challenges can affect outcomes, but strides in paediatric oncology and NGO partnerships continue to improve care access.
🔹 Next → [Causes and Risk Factors of ALL]
White House Clinic – Doncaster Physiotherapy
Symptoms and Warning Signs of Acute Lymphoblastic Leukaemia
Complications and Recovery Outlook of Acute Lymphoblastic Leukaemia
